Disse resultater viser, at selvom valdecoxib ikke metaboliseres af CYP2C19, kan det være en hæmmer af dette isoenzym.
These results indicate that although valdecoxib is not metabolised by CYP2C19, it may be an inhibitor of this isoenzyme.